Quick answers
- What is NoHist DM?
- NoHist DM is a brand name of Chlorpheniramine, dextromethorphan and phenylephrine, an over-the-counter medicine. The FDA NDC Directory lists 1 NoHist DM product in 1 strength and form.
- Who makes NoHist DM?
- Larken Laboratories, Inc. lists 1 of the 1 NoHist DM products in the FDA NDC Directory.
- Is there a generic or store brand of NoHist DM?
- Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a NoHist DM product, 1 of them generic or store brands. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for NoHist DM?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 NoHist DM strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has NoHist DM been recalled?
- FDA enforcement reports list 1 recall of NoHist DM products; the newest started March 15, 2021. A recall usually concerns specific lots, not every product.
What NoHist DM is
Each NoHist DM product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Chlorpheniramine, dextromethorphan and phenylephrine · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| chlorpheniramine maleate 4 mg/5 mL · dextromethorphan hydrobromide 15 mg/5 mL · phenylephrine hydrochloride 10 mg/5 mL liquid (oral) | NoHist DM | 1 product, 1 company | DailyMed |
Its page quotes the Drug Facts label and lists every brand and store brand: Chlorpheniramine, dextromethorphan and phenylephrine →
FDA approval
NoHist DM products are sold under an FDA over-the-counter monograph: rules that set the allowed active ingredients, strengths and label wording, so these products do not need an individual FDA approval.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| chlorpheniramine maleate 4 mg/5 mL · dextromethorphan hydrobromide 15 mg/5 mL · phenylephrine hydrochloride 10 mg/5 mL liquid | Generic: NoHist DM | $0.0668 per mL Generic of the same strength and form: $0.0668 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list NoHist DM
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of NoHist DM products.
- Larken Laboratories, Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 15, 2021 · Class II · Terminated · D-0507-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
NOHIST-DM Antihistamine/Antitussive Nasal Decongestant 16 fl. oz. (473 mL) NDC 68047-186-16 Distributed by: Larken Laboratories, Inc. Canton, MS 39046 — Cardinal Health Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.